Lastest Study Touts Benefits of Once a Week Injected Byetta

In one of those studies beloved by drug companies, three different drug regimens were compared against each other for a very brief period (six months) in a relatively small number of people (about 170 per regimen.) One of these drugs was long acting Byetta (LAR) which will be marketed as Bydureon if it ever gets approved by the FDA. That hasn't happened yet. While this study is being reported as showing long acting Byetta as superior to the other regimens, what it really showed was that none of

Diabetic Cake Recipes ...